Kayseri’de 2020 Yılı İlk Beş Ayının Ölüm Sayı Ve Nedenlerinin Bir Önceki Yıl İle Karşılaştırılması

Abstract

The spread of a new contagious disease across the world is called a pandemic. COVID-19 was declared as a pandemic by WHO on 11th March 2020. Although treatment modalities and vaccines are being developed against COVID-19 disease, COVID-19 related deaths continue and the rate of infectious diseases among all causes of death increases. In this study, we aimed to determine the effect of COVID-19 infection on mortality statistics by comparing mortality statistics in the first five months of 2020 with mortality statistics in the same period of 2019. Methods: This study was conducted by evaluating the death notification system data records using the ICD 10 diagnostic coding system for the first five months of 2019-2020 of the Kayseri Provincial Health Directorate, between 1 June 2020 and 1 July 2020. It is a retrospective study. In the study, data on dates (months) of deaths, ages, genders, marital statuses, causes of death and manners of death (infectious disease, forensic, natural death) in Kayseri were evaluated. Data were evaluated in SPSS (version 21.0) statistical package program. Results: There were 3349 deaths in the first 5 months of 2019, and 3491 deaths in the first five months of 2020. Of these, 54.6% were male and 45.4% were female. The monthly average numbers of death in 2019 and 2020 were similar. The rates of disease diagnoses differed in 2019 and 2020. In 2020, all-cause death numbers, including COVID-19, were higher among men. The total mortality rate of infectious diseases was 20.2% in 2019, and the mortality rate due to infectious diseases including COVID-19 was 20.1% in 2020. Conclusions: During the COVID-19 outbreak, there were significant changes in the rates of some specific causes of death. However, there was no significant change in the total number of deaths during the first five months in Kayseri province.

Diarylpentanoids, the privileged scaffolds in antimalarial and anti‐infectives drug discovery: A review

“…[3] The COVID-19 pandemic has exponentially increased the proportion of infectious diseases among all causes of death, suggesting a higher proportion of global mortality, especially in 2020-2022. [4] In addition, emerging respiratory infectious diseases, such as influenza also have an impact on global health and economy and therefore require prevention, effective antivirals, and vaccines. [5,6] It is worth mentioning that the exact percentage of global health problems attributable to infectious diseases is not clear, but the impact and prevalence may vary depending on factors such as region, population demographics, and specific diseases.…”

“…Biological vectors transmit and multiply pathogenic microorganisms within their bodies, whereas mechanical vectors transport infectious agents outside their bodies and transmit them through physical contact. [ 4 ] Statistically, vector‐borne infections contribute to approximately 17% of all infectious diseases. [ 12 ] Mosquito vectors such as Aedes , Anopheles , and Culex , for example, are associated with dengue fever, malaria, and Japanese encephalitis.…”